These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29875280)

  • 61. Can chromosomal instability initiate tumorigenesis?
    Michor F; Iwasa Y; Vogelstein B; Lengauer C; Nowak MA
    Semin Cancer Biol; 2005 Feb; 15(1):43-9. PubMed ID: 15613287
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Every which way? On predicting tumor evolution using cancer progression models.
    Diaz-Uriarte R; Vasallo C
    PLoS Comput Biol; 2019 Aug; 15(8):e1007246. PubMed ID: 31374072
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor suppressor genetics.
    Payne SR; Kemp CJ
    Carcinogenesis; 2005 Dec; 26(12):2031-45. PubMed ID: 16150895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Why Are Some Driver Mutations Rare?
    Nussinov R; Tsai CJ; Jang H
    Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Current topics in mutations in the cancer genome].
    Iwaya T; Mimori K; Wakabayashi G
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):185-90. PubMed ID: 22582578
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The null oncogene hypothesis and protection from cancer.
    Davenport MP; Ward RL; Hawkins NJ
    J Med Genet; 2002 Jan; 39(1):12-4. PubMed ID: 11826018
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Molecular therapy in malignant tumors].
    Fey MF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1758-63. PubMed ID: 10603649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IDENTIFY CANCER DRIVER GENES THROUGH SHARED MENDELIAN DISEASE PATHOGENIC VARIANTS AND CANCER SOMATIC MUTATIONS.
    Ma M; Wang C; Glicksberg BS; Schadt EE; Li SD; Chen R
    Pac Symp Biocomput; 2017; 22():473-484. PubMed ID: 27896999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect and evolution of gene expression noise on the fitness landscape.
    Charlebois DA
    Phys Rev E Stat Nonlin Soft Matter Phys; 2015 Aug; 92(2):022713. PubMed ID: 26382438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular evolution under fitness fluctuations.
    Mustonen V; Lässig M
    Phys Rev Lett; 2008 Mar; 100(10):108101. PubMed ID: 18352233
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lineage selection and the evolution of multistage carcinogenesis.
    Nunney L
    Proc Biol Sci; 1999 Mar; 266(1418):493-8. PubMed ID: 10189713
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Somatic clonal evolution: A selection-centric perspective.
    Scott J; Marusyk A
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Theory of evolutionary molecular engineering through simultaneous accumulation of advantageous mutations.
    Aita T; Husimi Y
    J Theor Biol; 2000 Dec; 207(4):543-56. PubMed ID: 11093838
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rate of adaptive peak shifts with partial genetic robustness.
    Kim Y
    Evolution; 2007 Aug; 61(8):1847-56. PubMed ID: 17683428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
    Zhang J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Passenger Hotspot Mutations in Cancer.
    Hess JM; Bernards A; Kim J; Miller M; Taylor-Weiner A; Haradhvala NJ; Lawrence MS; Getz G
    Cancer Cell; 2019 Sep; 36(3):288-301.e14. PubMed ID: 31526759
    [TBL] [Abstract][Full Text] [Related]  

  • 77. esiCancer: Evolutionary
    Minussi DC; Henz B; Dos Santos Oliveira M; Filippi-Chiela EC; Oliveira MM; Lenz G
    Cancer Res; 2019 Mar; 79(5):1010-1013. PubMed ID: 30563892
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fitness variation in isogenic populations leads to a novel evolutionary mechanism for crossing fitness valleys.
    Van Egeren D; Madsen T; Michor F
    Commun Biol; 2018; 1():151. PubMed ID: 30272027
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Quantitative selection constants.
    Kern SE
    Cancer Biol Ther; 2002; 1(2):189-94. PubMed ID: 12170779
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Too many mutants with multiple mutations.
    Drake JW
    Crit Rev Biochem Mol Biol; 2007; 42(4):247-58. PubMed ID: 17687667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.